Fortress Investment Group’s Biogen BIIB Stock Holding History

Fortress Investment Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-1,800	Closed	-$551K	–	142
2014 Q1	$551K	Buy	+1,800	New	+$571K	0.01%	102

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fortress Investment Group's BIIB Position: Q2 2014 in Review

Fortress Investment Group sold out of Biogen (BIIB) in Q2 2014, closing a stake of 1,800 shares — an estimated $551K sold.

Fortress Investment Group first reported a position in BIIB in Q1 2014 and held it in 1 quarter. The position peaked at $551K in Q1 2014. 782 funds tracked by Wall St. Rank hold BIIB as of Q2 2014.

Fortress Investment Group reported no remaining Biogen position as of Q2 2014 after selling out during the quarter.
Fortress Investment Group sold 1,800 Biogen shares in Q2 2014, an estimated $551K.
Fortress Investment Group first reported a position in Biogen in Q1 2014 and held it in 1 quarter.
Fortress Investment Group's Biogen position peaked at $551K in Q1 2014.
782 funds tracked by Wall St. Rank held Biogen as of Q2 2014.

Based on Fortress Investment Group's 13F filing for Q2 2014, filed 14 Aug 2014.